BioCardia BCDA
NASDAQ BCDA
$1.01 -0.02 (-1.92%)
As of: Sep 30, 2026 · 3:56 PM EDT

BioCardia (BCDA) Research & Development (2016 - 2026)

Updated

BioCardia (BCDA) reported Research & Development of $893,000 for Q2 2026, down 34.7% from $1.37 million a year earlier and down 27.7% from the prior quarter.

Analysis

BioCardia (BCDA) Research & Development (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, BioCardia's Research & Development came in at $4.19 million, down 20.1% year-over-year; for FY2025, it was $4.96 million, up 13.1% from FY2024.

  • Research & Development has a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
  • By year, Research & Development came in at $4.39 million in FY2024 (-43.2%), $7.73 million in FY2023 (-12.5%), $8.83 million in FY2022 (+3.2%) and $8.56 million in FY2021 (-12.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q2 2024.
  • Year over year, Research & Development has now declined in each of the last three quarters, with an average decline of 0.9% over the last eight quarters.
  • The high point for year-over-year Research & Development in five years was Q2 2025 (growth of 71.0%); the low point was Q2 2024 (a decline of 65.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.24 million (Q1 2026), $1.13 million (Q4 2025) and $936,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 3.65 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.34 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -4.05 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 993.80 Mn
10 BioCardia 12.46 Mn -407,934.31 - 893,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 893,000.00
Mar 31, 2026 1.24 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 936,000.00
Jun 30, 2025 1.37 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 1.42 Mn
Sep 30, 2024 931,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 1.24 Mn
Dec 31, 2023 1.16 Mn
Sep 30, 2023 1.87 Mn
Jun 30, 2023 2.31 Mn
Mar 31, 2023 2.38 Mn
Dec 31, 2022 2.20 Mn
Sep 30, 2022 2.14 Mn
Jun 30, 2022 2.30 Mn
Mar 31, 2022 2.19 Mn
Dec 31, 2021 2.12 Mn
Sep 30, 2021 2.24 Mn
API Access

BioCardia Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=BCDA&period=max&api_key=YOUR_API_KEY